1 | pressure | 60,529 |
2 | stopper | 25 |
3 | flow/perfusion | 6 |
4 | presure | 4 |
5 | 3-ohb | 3 |
6 | echoreflectivity | 3 |
7 | antiestrogenicity | 2 |
8 | pressure= | 2 |
9 | rsv-igm | 2 |
10 | stem-cells | 2 |
11 | 110ng/ml | 1 |
12 | 3-hydroxy-isovalerylcarnitine | 1 |
13 | arterial-lv | 1 |
14 | aserved | 1 |
15 | banking/immunohematology | 1 |
16 | buckberg-cardioplegia | 1 |
17 | cell-hba1c | 1 |
18 | disinfectively | 1 |
19 | donations=1.32 | 1 |
20 | drops/time | 1 |
21 | flow-interactions | 1 |
22 | flow-occluding | 1 |
23 | flow-tb | 1 |
24 | flow/pam | 1 |
25 | gas-metabolite | 1 |
26 | gases/ph | 1 |
27 | glucose/hba1c | 1 |
28 | group-compatible | 1 |
29 | group-incompatible | 1 |
30 | hetero-lymphocyte | 1 |
31 | impassability | 1 |
32 | loss/cm | 1 |
33 | loss=-249.75ml | 1 |
34 | mehionine | 1 |
35 | monocyte-to-lymphocyte | 1 |
36 | monocyts | 1 |
37 | oxygen-level-dependent | 1 |
38 | pres.sures | 1 |
39 | pressue | 1 |
40 | pressure+13 | 1 |
41 | pressure-8 | 1 |
42 | pressure-calcium | 1 |
43 | pressure-compliant | 1 |
44 | pressure.there | 1 |
45 | pressure.treatment | 1 |
46 | pressure/appropriate | 1 |
47 | pressure/bapwv | 1 |
48 | pressure/hypertension | 1 |
49 | pressure/tav | 1 |
50 | pressures≥80mmhg | 1 |
51 | pressure÷95 | 1 |
52 | pressure÷kmono | 1 |
53 | pressure≤60mmhg | 1 |
1 | 110ng/ml | 1 |
2 | 3-hydroxy-isovalerylcarnitine | 1 |
3 | 3-ohb | 3 |
4 | antiestrogenicity | 2 |
5 | arterial-lv | 1 |
6 | aserved | 1 |
7 | banking/immunohematology | 1 |
8 | buckberg-cardioplegia | 1 |
9 | cell-hba1c | 1 |
10 | disinfectively | 1 |
11 | donations=1.32 | 1 |
12 | drops/time | 1 |
13 | echoreflectivity | 3 |
14 | flow-interactions | 1 |
15 | flow-occluding | 1 |
16 | flow-tb | 1 |
17 | flow/pam | 1 |
18 | flow/perfusion | 6 |
19 | gas-metabolite | 1 |
20 | gases/ph | 1 |
21 | glucose/hba1c | 1 |
22 | group-compatible | 1 |
23 | group-incompatible | 1 |
24 | hetero-lymphocyte | 1 |
25 | impassability | 1 |
26 | loss/cm | 1 |
27 | loss=-249.75ml | 1 |
28 | mehionine | 1 |
29 | monocyte-to-lymphocyte | 1 |
30 | monocyts | 1 |
31 | oxygen-level-dependent | 1 |
32 | pres.sures | 1 |
33 | pressue | 1 |
34 | pressure | 60,529 |
35 | pressure+13 | 1 |
36 | pressure-8 | 1 |
37 | pressure-calcium | 1 |
38 | pressure-compliant | 1 |
39 | pressure.there | 1 |
40 | pressure.treatment | 1 |
41 | pressure/appropriate | 1 |
42 | pressure/bapwv | 1 |
43 | pressure/hypertension | 1 |
44 | pressure/tav | 1 |
45 | pressure= | 2 |
46 | pressures≥80mmhg | 1 |
47 | pressure÷95 | 1 |
48 | pressure÷kmono | 1 |
49 | pressure≤60mmhg | 1 |
50 | presure | 4 |
51 | rsv-igm | 2 |
52 | stem-cells | 2 |
53 | stopper | 25 |
1 | donations=1.32 | 1 |
2 | pressure+13 | 1 |
3 | pressure÷95 | 1 |
4 | pressure-8 | 1 |
5 | pressure= | 2 |
6 | buckberg-cardioplegia | 1 |
7 | 3-ohb | 3 |
8 | flow-tb | 1 |
9 | cell-hba1c | 1 |
10 | glucose/hba1c | 1 |
11 | aserved | 1 |
12 | group-compatible | 1 |
13 | group-incompatible | 1 |
14 | drops/time | 1 |
15 | mehionine | 1 |
16 | 3-hydroxy-isovalerylcarnitine | 1 |
17 | pressure.there | 1 |
18 | presure | 4 |
19 | pressure | 60,529 |
20 | pressure/appropriate | 1 |
21 | gas-metabolite | 1 |
22 | hetero-lymphocyte | 1 |
23 | monocyte-to-lymphocyte | 1 |
24 | pressue | 1 |
25 | pressure≤60mmhg | 1 |
26 | pressures≥80mmhg | 1 |
27 | flow-occluding | 1 |
28 | gases/ph | 1 |
29 | 110ng/ml | 1 |
30 | loss=-249.75ml | 1 |
31 | flow/pam | 1 |
32 | loss/cm | 1 |
33 | rsv-igm | 2 |
34 | pressure-calcium | 1 |
35 | pressure/hypertension | 1 |
36 | flow/perfusion | 6 |
37 | pressure÷kmono | 1 |
38 | stopper | 25 |
39 | pres.sures | 1 |
40 | stem-cells | 2 |
41 | flow-interactions | 1 |
42 | monocyts | 1 |
43 | pressure-compliant | 1 |
44 | oxygen-level-dependent | 1 |
45 | pressure.treatment | 1 |
46 | pressure/tav | 1 |
47 | arterial-lv | 1 |
48 | pressure/bapwv | 1 |
49 | banking/immunohematology | 1 |
50 | disinfectively | 1 |
51 | antiestrogenicity | 2 |
52 | impassability | 1 |
53 | echoreflectivity | 3 |